Skip to main content
. Author manuscript; available in PMC: 2020 Jul 21.
Published in final edited form as: Sci Transl Med. 2019 Jan 16;11(475):eaat2702. doi: 10.1126/scitranslmed.aat2702

Figure 4. Mtb-specific antibody responses in a patient with MCC after pembrolizumab treatment.

Figure 4.

IgG against mycobacterial antigens measured in sera from the MCC patient at different points after PD-1 blockade. Error bars depict ±SEM of duplicate wells.